Loading clinical trials...
Loading clinical trials...
Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode: Prospective, Multicentric, Comparative, Single Blind Clinical Investigation. EMC1 Study
Conditions
Interventions
EMOCARE software
Locations
11
France
Private psychiatric practice
Agen, France
Private psychiatric pratice
Caen, France
Centre Psychothérapique de Nancy
Laxou, France
Private psychiatric practice
Maxéville, France
Private psychiatric practice
Nantes, France
Centre Hospitalier Universitaire de Nantes
Nantes, France
Start Date
March 5, 2025
Primary Completion Date
February 4, 2027
Completion Date
February 4, 2027
Last Updated
February 19, 2026
NCT07523048
NCT07226661
NCT06793397
NCT07025720
NCT06804525
NCT07462013
Lead Sponsor
Emobot
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions